Business Context and Reporting Period
Company: Recursion Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 24, 2024
Event: Regulation FD Disclosure regarding announcements made during the company's "Download Day" investor meeting.
Financial Metrics
This filing is a disclosure of non-financial events and does not contain specific financial statements. The text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes versus prior periods are reported in this document. The filing serves to disseminate information contained in a press release and an updated investor presentation attached as exhibits.
Guidance, Outlook, and Management Commentary
- Management Commentary: The Company issued a press release and an updated investor presentation on June 24, 2024, related to its Download Day investor meeting.
- Legal Status of Information: The information furnished in this Item 7.01 (including the press release and investor presentation) is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
- Exhibits:
- Exhibit 99.1: Press Release dated June 24, 2024.
- Exhibit 99.2: Investor Presentation dated June 24, 2024.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Press Release) for specific details on the announcements made during the Download Day investor meeting.
- Review Exhibit 99.2 (Investor Presentation) for updated strategic outlook and operational data.
- Note that the content of the exhibits is not legally "filed" under Section 18 of the Exchange Act unless expressly incorporated by reference in another filing.
- Verify the company's current financial position through its most recent 10-Q or 10-K, as this 8-K does not contain financial data.